Publications (64) Maite Solas Zubiaurre publications

filter_list

2025

  1. Microglial SIRT2 deficiency aggravates cognitive decline and amyloid pathology in Alzheimer's disease

    Brain, Behavior, and Immunity, Vol. 129, pp. 223-243

2024

  1. Astrocytic Ca2+ activation by chemogenetics mitigates the effect of kainic acid-induced excitotoxicity on the hippocampus

    GLIA, Vol. 72, Núm. 12, pp. 2217-2230

  2. Astrocytic GLUT1 reduction paradoxically improves central and peripheral glucose homeostasis

    Science Advances , Vol. 10, Núm. 42

  3. Essential Role of Astrocytes in Learning and Memory

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

  4. Neuropathological stage-dependent proteome mapping of the olfactory tract in Alzheimer's disease: From early olfactory-related omics signatures to computational repurposing of drug candidates

    Brain Pathology, Vol. 34, Núm. 4

  5. Novel Pitolisant-Derived Sulfonyl Compounds for Alzheimer Disease

    International Journal of Molecular Sciences, Vol. 25, Núm. 2

  6. The dual GLP-1/glucagon receptor agonist G49 mimics bariatric surgery effects by inducing metabolic rewiring and inter-organ crosstalk

    Nature Communications , Vol. 15, Núm. 1

  7. Zein nanoparticles extend lifespan in C. elegans and SAMP8 mice

    International Journal of Pharmaceutics, Vol. 666

2023

  1. Editorial: New insights into the role of neuroinflammation and glial cells in the development of neurological disorders

    Frontiers in Cellular Neuroscience

  2. JNK Activation in Alzheimer’s Disease Is Driven by Amyloid β and Is Associated with Tau Pathology

    ACS Chemical Neuroscience

  3. JNK3 Overexpression in the Entorhinal Cortex Impacts on the Hippocampus and Induces Cognitive Deficiencies and Tau Misfolding

    ACS Chemical Neuroscience, Vol. 14, Núm. 11, pp. 2074-2088

  4. Metabolic Syndrome as a Risk Factor for Alzheimer’s Disease: A Focus on Insulin Resistance

    International Journal of Molecular Sciences, Vol. 24, Núm. 5

  5. SIRT2 Inhibition Rescues Neurodegenerative Pathology but Increases Systemic Inflammation in a Transgenic Mouse Model of Alzheimer’s Disease

    Journal of Neuroimmune Pharmacology, Vol. 18, Núm. 3, pp. 529-550

  6. Trimethylamine N-Oxide as a Mediator Linking Peripheral to Central Inflammation: An In Vitro Study

    International Journal of Molecular Sciences, Vol. 24, Núm. 24

2022

  1. Brain Metabolic Alterations in Alzheimer’s Disease

    International Journal of Molecular Sciences, Vol. 23, Núm. 7

  2. Dysbiosis and Alzheimer’s Disease: Cause or Treatment Opportunity?

    Cellular and Molecular Neurobiology, Vol. 42, Núm. 2, pp. 377-387

  3. The Cognitive Improvement and Alleviation of Brain Hypermetabolism Caused by FFAR3 Ablation in Tg2576 Mice Is Persistent under Diet-Induced Obesity

    International Journal of Molecular Sciences, Vol. 23, Núm. 21

  4. Trimethylamine N-oxide (TMAO) drives insulin resistance and cognitive deficiencies in a senescence accelerated mouse model

    Mechanisms of Ageing and Development, Vol. 204

2021

  1. 5-HT7 receptors in Alzheimer's disease

    Neurochemistry International, Vol. 150

  2. Astrocytic GLUT1 ablation improves systemic glucose metabolism and promotes cognition

    Alzheimer's & dementia : the journal of the Alzheimer's Association, Vol. 17, pp. e058650